Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 1906 AL 1920

The Efficacy and Safety of Transcranial Photobiomodulation for Mild Cognitive Impairment Due to Alzheimer's Disease: A Randomized, Double-Blind, Sham-Controlled Study

Chun H, Yoon ML, Lee HW, Lee JY, Hong SB, Ha SS, Yoon KJ.

Photobiomodul Photomed Laser Surg. 2025 Sep;43(9):411-416. doi: 10.1177/15578550251369575.

The cost-effectiveness of an online intervention to prevent dementia: Results from the Maintain Your Brain (MYB) randomised controlled trial

Welberry HJ, Ku LE, Shih ST, Jorm LR, Singh MF, Valenzuela M, Anupama Ginige J, Anstey KJ, Sachdev PS, McNeil JJ, Lautenschlager NT, Heffernan M, Chau T, Brodaty H.

J Prev Alzheimers Dis. 2025 Jun;12(6):100151. doi: 10.1016/j.tjpad.2025.100151. Epub 2025 Apr 3.

Diagnostic journey and management of patients with mild cognitive impairment and Alzheimer's disease dementia: A multinational, real-world survey

Vasileva-Metodiev SZ, Spargo D, Klein EG, Quevenco FC, Cotton S, Sanchez-Juan P, Niimi Y, Fowler NR.

J Alzheimers Dis. 2025 Apr;104(4):1212-1234. doi: 10.1177/13872877251322978. Epub 2025 Mar 20.

Diagnostic and prognostic multimodal prediction models in Alzheimer's disease: A scoping review

Xia X, Duffner LA, Bintener C, Bradshaw A, Lamirel D, Jönsson L.

J Alzheimers Dis. 2025 Nov;108(1_suppl):S209-S221. doi: 10.1177/13872877251351630. Epub 2025 Jun 26.

The role of atrial fibrillation in vascular cognitive impairment and dementia: epidemiology, pathophysiology, and preventive strategies

Fekete M, Liotta EM, Molnar T, Fülöp GA, Lehoczki A.

Geroscience. 2025 Feb;47(1):287-300. doi: 10.1007/s11357-024-01290-1. Epub 2024 Aug 13.

Associations of metabolic syndrome with risks of dementia and cognitive impairment: A systematic review and meta-analysis

Qiu SD, Zhang DD, Ma LY, Li QY, Wang LY, Wang YD, Wang YC, Xiong SY, Tan L.

J Alzheimers Dis. 2025 May;105(1):15-27. doi: 10.1177/13872877251326553. Epub 2025 Mar 20.

Neuropsychological test performance in mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis

Wyman-Chick KA, Bayram E, Gravett S, D'Antonio F, Rodriguez-Porcel F, Kane JPM, Ferman TJ, Olson-Bullis BA, Boeve BF, Bonanni L, Ferreira D; Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) Lewy Body Dementias Professional Interest Area (LBD PIA) Prodromal Working Group.

Alzheimers Dement. 2025 Feb;21(2):e14450. doi: 10.1002/alz.14450. Epub 2025 Jan 10.

Cognitive trajectories and dementia risk in patients with schizophrenia spectrum versus affective disorders

Liu KY, Perera G, Howard R, Mueller C.

Psychol Med. 2025 Sep 30;55:e286. doi: 10.1017/S0033291725101864.

The intersection of delirium and long-term cognition in older adults: the critical role of delirium prevention

Lu Z, Wang X, Wang J, Zhao L, Wu Y, Sun M, Zhang J.

J Neurol. 2025 May 6;272(6):381. doi: 10.1007/s00415-025-13104-1.

Remote, lower-intensity, multidomain lifestyle intervention for subjective cognitive decline or mild cognitive impairment (APPLE-Tree): a multicentre, single-masked, randomised controlled trial

Demnitz-King H, Adeleke M, Barber JA, Poppe M, Budgett J, Alberts S, Duffy L, Minihane AM, Gillings R, Chapman H, Espinoza Jeraldo RI, Kelsey O, Muralidhar M, Zabihi S, Aguirre E, Bass N, Betz A, Brodaty H, Burton A, Higgs P, Hunter RM, Huntley J, Kales HC, Lang I, Marchant NL, Morgan-Trimmer S, Rapaport P, Rio M, Petersen I, Walker Z, Walters K, Banerjee S, Rodda J, Palomo M, Cooper C.

Lancet Healthy Longev. 2025 Oct;6(10):100777. doi: 10.1016/j.lanhl.2025.100777. Epub 2025 Oct 20.

Neuropsychiatric symptoms and neuroimaging-based brain age in mild cognitive impairment and early dementia: A multicenter study

Sone D, Beheshti I, Tagai K, Kameyama H, Takasaki E, Kashibayashi T, Takahashi R, Ishii K, Kanemoto H, Ikeda M, Shigeta M, Shinagawa S, Kazui H.

Psychiatry Clin Neurosci. 2025 Apr;79(4):158-164. doi: 10.1111/pcn.13777. Epub 2025 Jan 17.

Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial

Squitti R, Benussi A, Fostinelli S, Geviti A, Rivolta J, Ventriglia M, Micera A, Rongioletti M, Ghidoni R, Santilli M, Granzotto A, Albanese A, Binetti G, Sensi SL, Borroni B.

Biomolecules. 2025 Sep 1;15(9):1268. doi: 10.3390/biom15091268.

Effectiveness of Individual Cognitive Stimulation on Cognition in Mild Alzheimer's Disease: A Multicenter RCT

Justo-Henriques SI, Lemos R, Rahmatpour P, Silva RCG, Carvalho JO, Ribeiro O.

Psychogeriatrics. 2025 Nov;25(6):e70109. doi: 10.1111/psyg.70109.

Cognitive markers of resilience to dementia in mild Neurocognitive Impairment: a meta- analysis

Raimo S, Gaita M, Cropano M, Ammendola L, Malangone D, Torchia V, Aquino M, Roldan-Tapia MD, Trojano L, Santangelo G.

Neurol Sci. 2025 Jun;46(6):2401-2418. doi: 10.1007/s10072-025-08080-3. Epub 2025 Mar 3.

Total and Structural Carotid Artery Stiffness Are Associated With Cognitive Decline and Structural Brain Abnormalities Related to Alzheimer Disease and Alzheimer Disease-Related Dementias Pathology: The Multi-Ethnic Study of Atherosclerosis

Williams JR, DeConne TM, Pewowaruk R, Korcarz C, Tanley J, Carlsson C, Heckbert SR, Habes M, Nasrallah I, Lockhart SN, Luchsinger JA, Ding J, Hayden KM, Hughes TM, Gepner AD.

J Am Heart Assoc. 2025 May 6;14(9):e039925. doi: 10.1161/JAHA.124.039925. Epub 2025 May 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias